Zero Candida Technologies
AI-enabled Blue-light Vaginal Device for at-home VVC Treatment and Monitoring
Company Overview
Snapshot
Founded in January 2022 by Eli Ben Haroosh and Asher Holzer, Zero Candida Technologies operates with 11–50 employees. The company became public on the TSX Venture Exchange in November 2024.
Business overview
Zero Candida Technologies is a FemTech company developing an AI-enabled smart tampon-like device that utilizes a therapeutic blue light source for the at-home treatment and monitoring of Vulvo-Vaginal Candidiasis (VVC). This medical device aims to provide a chemical-free solution for women's health, offering a novel approach to treating vaginal fungus without side effects. The device also collects and transmits treatment data in real-time to physicians, enabling remote care, personalized treatment, and monitoring. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics for women.
Strategic signal
In February 2026, Zero Candida Technologies scaled production to 250 ISO 13485 clinical-grade prototypes of its ZC-001 therapeutic device. This development is a significant step towards commercialization, indicating the company's progress in manufacturing and quality assurance for its innovative FemTech solution. For investors, this signals a maturing product development cycle and a move closer to market readiness, potentially de-risking future investment.
Log in to access full profile ›Company Intelligence Q&A
- What is Zero Candida Technologies' primary product?
- Zero Candida Technologies' primary product is the ZC-001, an AI-enabled blue-light vaginal device designed for at-home treatment and monitoring of Vulvo-Vaginal Candidiasis (VVC).
- When did Zero Candida Technologies become a public company?
- Zero Candida Technologies became public on the TSX Venture Exchange in November 2024.
- What significant production milestone did Zero Candida Technologies achieve in early 2026?
- In February 2026, Zero Candida Technologies scaled production to 250 ISO 13485 clinical-grade prototypes of its ZC-001 therapeutic device.
- Who are the co-founders of Zero Candida Technologies?
- Zero Candida Technologies was co-founded by Eli Ben Haroosh and Asher Holzer.
- What was a key development for the ZC-001 device in late 2025?
- In October 2025, Zero Candida Technologies achieved design freeze and began prototype production of its ZC-001 therapeutic device.